SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3v9e'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OE1_A_CUA501_0
(DISSIMILATORY
COPPER-CONTAINING
NITRITE REDUCTASE)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
HIS A 494
MET A 499
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-3.1A)
CU  A 601 (-3.1A)
 0.47A 1oe1A-3v9eA:
18.7		 1oe1A-3v9eA:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OE2_A_CUA501_0
(DISSIMILATORY
COPPER-CONTAINING
NITRITE REDUCTASE)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 HIS A 426
CYH A 489
HIS A 494
MET A 499
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-3.1A)
CU  A 601 (-3.1A)
 0.47A 1oe2A-3v9eA:
17.7		 1oe2A-3v9eA:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OE2_A_CUA501_0
(DISSIMILATORY
COPPER-CONTAINING
NITRITE REDUCTASE)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 HIS A 426
CYH A 489
PRO A 427
MET A 499
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
GOL  A 607 (-3.8A)
CU  A 601 (-3.1A)
 1.32A 1oe2A-3v9eA:
17.7		 1oe2A-3v9eA:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OE3_A_CUA501_0
(DISSIMILATORY
COPPER-CONTAINING
NITRITE REDUCTASE)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
HIS A 494
MET A 499
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-3.1A)
CU  A 601 (-3.1A)
 0.51A 1oe3A-3v9eA:
18.7		 1oe3A-3v9eA:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RMT_D_ADND1504_1
(CLASS B ACID
PHOSPHATASE)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 8 TYR A 118
LEU A 116
ASP A 114
THR A 106
 None
 1.12A 1rmtD-3v9eA:
undetectable		 1rmtD-3v9eA:
17.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XF1_A_ACTA1107_0
(C5A PEPTIDASE)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 LEU A 142
HIS A 131
ILE A  86
PHE A 134
 None
CU  A 603 (-3.2A)
None
None
 0.98A 1xf1A-3v9eA:
1.6		 1xf1A-3v9eA:
19.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQD_A_CUA601_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
HIS A 494
MET A 499
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-3.1A)
CU  A 601 (-3.1A)
 0.22A 2fqdA-3v9eA:
29.8		 2fqdA-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQE_A_CUA601_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
HIS A 494
MET A 499
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-3.1A)
CU  A 601 (-3.1A)
 0.15A 2fqeA-3v9eA:
29.9		 2fqeA-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQE_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.34A 2fqeA-3v9eA:
29.9		 2fqeA-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQE_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.28A 2fqeA-3v9eA:
29.9		 2fqeA-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQE_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 488
HIS A 429
HIS A 431
HIS A 133
 CU  A 602 (-3.1A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.3A)
 1.32A 2fqeA-3v9eA:
29.9		 2fqeA-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQF_A_CUA601_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
HIS A 494
MET A 499
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-3.1A)
CU  A 601 (-3.1A)
 0.17A 2fqfA-3v9eA:
29.8		 2fqfA-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQF_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.45A 2fqfA-3v9eA:
29.8		 2fqfA-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQF_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.31A 2fqfA-3v9eA:
29.8		 2fqfA-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQF_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 488
HIS A 429
HIS A 431
HIS A 133
 CU  A 602 (-3.1A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.3A)
 1.35A 2fqfA-3v9eA:
29.8		 2fqfA-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQG_A_CUA601_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
HIS A 494
MET A 499
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-3.1A)
CU  A 601 (-3.1A)
 0.17A 2fqgA-3v9eA:
29.8		 2fqgA-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQG_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.49A 2fqgA-3v9eA:
29.8		 2fqgA-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQG_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.35A 2fqgA-3v9eA:
29.8		 2fqgA-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQG_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 488
HIS A 429
HIS A  89
HIS A 490
 CU  A 602 (-3.1A)
CU  A 602 (-3.6A)
CU  A 603 (-2.9A)
CU  A 603 (-3.5A)
 1.33A 2fqgA-3v9eA:
29.8		 2fqgA-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FQG_A_CUA603_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 488
HIS A 429
HIS A 431
HIS A 133
 CU  A 602 (-3.1A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.3A)
 1.36A 2fqgA-3v9eA:
29.8		 2fqgA-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OXT_C_SAMC300_1
(NUCLEOSIDE-2'-O-METH
YLTRANSFERASE)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 SER A 298
GLY A 294
HIS A 490
ASP A 463
 GOL  A 607 ( 4.7A)
None
CU  A 603 (-3.5A)
None
 1.19A 2oxtC-3v9eA:
undetectable		 2oxtC-3v9eA:
16.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q72_A_IXXA801_1
(TRANSPORTER)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 11 LEU A 146
ARG A 273
ILE A  91
ASP A 434
ASP A 463
 None
 0.96A 2q72A-3v9eA:
undetectable		 2q72A-3v9eA:
21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QB4_A_DSMA801_1
(TRANSPORTER)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 12 LEU A 146
ARG A 273
ILE A  91
ASP A 434
ASP A 463
 None
 0.96A 2qb4A-3v9eA:
undetectable		 2qb4A-3v9eA:
21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QEI_A_CXXA801_1
(TRANSPORTER)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 11 LEU A 146
ARG A 273
ILE A  91
ASP A 434
ASP A 463
 None
 0.99A 2qeiA-3v9eA:
undetectable		 2qeiA-3v9eA:
21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QEI_A_CXXA801_1
(TRANSPORTER)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 11 LEU A 146
ARG A 273
ILE A  91
ASP A 434
ASP A 463
 None
 1.23A 2qeiA-3v9eA:
undetectable		 2qeiA-3v9eA:
21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QJU_A_DSMA801_1
(TRANSPORTER)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 11 LEU A 146
ARG A 273
ILE A  91
ASP A 434
ASP A 463
 None
 1.00A 2qjuA-3v9eA:
undetectable		 2qjuA-3v9eA:
21.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QWX_B_ML1B233_1
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])		 3v9e LACCASE
(Botrytis
aclada) 		4 / 7 GLY A 483
GLY A 104
PHE A 520
PHE A 387
 None
 0.86A 2qwxA-3v9eA:
undetectable
2qwxB-3v9eA:
undetectable		 2qwxA-3v9eA:
16.84
2qwxB-3v9eA:
16.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W0Q_A_CUA801_0
(COPPER AMINE OXIDASE)		 3v9e LACCASE
(Botrytis
aclada) 		3 / 3 HIS A 488
HIS A 490
HIS A 429
 CU  A 602 (-3.1A)
CU  A 603 (-3.5A)
CU  A 602 (-3.6A)
 0.66A 2w0qA-3v9eA:
undetectable		 2w0qA-3v9eA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W0Q_B_CUB801_0
(COPPER AMINE OXIDASE)		 3v9e LACCASE
(Botrytis
aclada) 		3 / 3 HIS A 488
HIS A 490
HIS A 429
 CU  A 602 (-3.1A)
CU  A 603 (-3.5A)
CU  A 602 (-3.6A)
 0.71A 2w0qB-3v9eA:
undetectable		 2w0qB-3v9eA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WKO_A_CUA154_0
(SUPEROXIDE DISMUTASE
[CU-ZN])		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A 133
HIS A 131
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 602 (-3.3A)
CU  A 603 (-3.2A)
CU  A 602 (-3.1A)
 1.04A 2wkoA-3v9eA:
undetectable		 2wkoA-3v9eA:
13.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WKO_A_CUA154_0
(SUPEROXIDE DISMUTASE
[CU-ZN])		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  89
HIS A  87
HIS A 131
HIS A 429
 CU  A 603 (-2.9A)
CU  A 602 ( 4.7A)
CU  A 603 (-3.2A)
CU  A 602 (-3.6A)
 1.09A 2wkoA-3v9eA:
undetectable		 2wkoA-3v9eA:
13.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WKO_F_CUF154_0
(SUPEROXIDE DISMUTASE
[CU-ZN])		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 HIS A  87
HIS A 133
VAL A 102
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 602 (-3.3A)
None
CU  A 602 (-3.1A)
 0.79A 2wkoF-3v9eA:
undetectable		 2wkoF-3v9eA:
13.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XXG_A_CUA1337_0
(DISSIMILATORY
COPPER-CONTAINING
NITRITE REDUCTASE)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
HIS A 494
MET A 499
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-3.1A)
CU  A 601 (-3.1A)
 0.46A 2xxgA-3v9eA:
18.9		 2xxgA-3v9eA:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XXG_C_CUC1338_0
(DISSIMILATORY
COPPER-CONTAINING
NITRITE REDUCTASE)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 HIS A 426
CYH A 489
HIS A 494
MET A 499
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-3.1A)
CU  A 601 (-3.1A)
 0.48A 2xxgC-3v9eA:
18.8		 2xxgC-3v9eA:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XXG_C_CUC1338_0
(DISSIMILATORY
COPPER-CONTAINING
NITRITE REDUCTASE)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 HIS A 426
CYH A 489
PRO A 427
MET A 499
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
GOL  A 607 (-3.8A)
CU  A 601 (-3.1A)
 1.27A 2xxgC-3v9eA:
18.8		 2xxgC-3v9eA:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7H_B_SAMB530_0
(TYPE I RESTRICTION
ENZYME ECOKI M
PROTEIN)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 12 ILE A  73
GLY A 101
THR A 383
LEU A 384
PHE A 520
 None
 1.06A 2y7hB-3v9eA:
undetectable		 2y7hB-3v9eA:
21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7H_C_SAMC530_0
(TYPE I RESTRICTION
ENZYME ECOKI M
PROTEIN)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 12 ILE A  73
GLY A 101
THR A 383
LEU A 384
PHE A 520
 None
 1.06A 2y7hC-3v9eA:
undetectable		 2y7hC-3v9eA:
21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7P_A_SALA1001_1
(LYSR-TYPE REGULATORY
PROTEIN)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 6 SER A  85
PRO A 381
GLY A 104
TRP A 527
 None
 1.26A 2y7pA-3v9eA:
undetectable		 2y7pA-3v9eA:
15.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7W_B_SALB1300_1
(LYSR-TYPE REGULATORY
PROTEIN)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 10 THR A  53
GLY A 141
PHE A 143
GLY A  60
PRO A  44
 None
 1.23A 2y7wB-3v9eA:
undetectable		 2y7wB-3v9eA:
16.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BWM_A_SAMA301_0
(CATECHOL
O-METHYLTRANSFERASE)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 12 GLY A 101
TYR A  99
ILE A  86
SER A 132
GLN A 137
 None
 1.45A 3bwmA-3v9eA:
undetectable		 3bwmA-3v9eA:
14.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BWY_A_SAMA301_0
(COMT PROTEIN)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 12 GLY A 101
TYR A  99
ILE A  86
SER A 132
GLN A 137
 None
 1.39A 3bwyA-3v9eA:
undetectable		 3bwyA-3v9eA:
14.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HY7_B_097B801_1
(A DISINTEGRIN AND
METALLOPROTEINASE
WITH THROMBOSPONDIN
MOTIFS 5)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 9 HIS A  89
HIS A 131
HIS A 490
ILE A 428
LEU A 430
 CU  A 603 (-2.9A)
CU  A 603 (-3.2A)
CU  A 603 (-3.5A)
None
None
 1.24A 3hy7B-3v9eA:
undetectable		 3hy7B-3v9eA:
16.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ITA_D_AICD501_1
(D-ALANYL-D-ALANINE
CARBOXYPEPTIDASE
DACC)		 3v9e LACCASE
(Botrytis
aclada) 		3 / 3 PRO A 460
PHE A 435
ALA A 465
 None
 0.70A 3itaD-3v9eA:
undetectable		 3itaD-3v9eA:
22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LXE_A_TORA262_1
(CARBONIC ANHYDRASE 1)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 12 HIS A 429
GLN A  93
VAL A 122
LEU A 146
HIS A  89
 CU  A 602 (-3.6A)
None
None
None
CU  A 603 (-2.9A)
 1.27A 3lxeA-3v9eA:
undetectable		 3lxeA-3v9eA:
19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NK2_X_LDPX433_1
(6-HYDROXY-L-NICOTINE
OXIDASE)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 7 TYR A  22
LEU A 479
PHE A 436
TRP A 411
 None
 1.23A 3nk2X-3v9eA:
undetectable		 3nk2X-3v9eA:
20.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NVC_A_SALA370_1
(GENTISATE
1,2-DIOXYGENASE)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 6 GLN A 124
HIS A  89
HIS A 429
HIS A  87
 None
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 ( 4.7A)
 1.23A 3nvcA-3v9eA:
undetectable		 3nvcA-3v9eA:
19.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OU6_C_SAMC300_1
(SAM-DEPENDENT
METHYLTRANSFERASE)		 3v9e LACCASE
(Botrytis
aclada) 		3 / 3 TYR A 138
GLY A 234
ASP A 167
 None
 0.67A 3ou6C-3v9eA:
undetectable		 3ou6C-3v9eA:
18.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QOW_A_SAMA417_1
(HISTONE-LYSINE
N-METHYLTRANSFERASE)		 3v9e LACCASE
(Botrytis
aclada) 		3 / 3 THR A   7
ASP A 157
GLU A 279
 None
 0.85A 3qowA-3v9eA:
undetectable		 3qowA-3v9eA:
20.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_A_CUA601_0
(LACCASE-1)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 HIS A 426
CYH A 489
ILE A 491
HIS A 494
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-4.0A)
CU  A 601 (-3.1A)
 0.30A 3qpkA-3v9eA:
52.2		 3qpkA-3v9eA:
37.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_A_CUA602_0
(LACCASE-1)		 3v9e LACCASE
(Botrytis
aclada) 		3 / 3 HIS A 133
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.29A 3qpkA-3v9eA:
52.2		 3qpkA-3v9eA:
37.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_A_CUA603_0
(LACCASE-1)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  89
TRP A 129
HIS A 131
HIS A 490
 CU  A 603 (-2.9A)
CU  A 603 (-4.0A)
CU  A 603 (-3.2A)
CU  A 603 (-3.5A)
 0.34A 3qpkA-3v9eA:
52.2		 3qpkA-3v9eA:
37.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_A_CUA604_0
(LACCASE-1)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.45A 3qpkA-3v9eA:
52.2		 3qpkA-3v9eA:
37.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_A_CUA604_0
(LACCASE-1)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 429
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 1.17A 3qpkA-3v9eA:
52.2		 3qpkA-3v9eA:
37.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_A_CUA604_0
(LACCASE-1)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.30A 3qpkA-3v9eA:
52.2		 3qpkA-3v9eA:
37.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_A_CUA604_0
(LACCASE-1)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 488
HIS A 429
HIS A 431
HIS A 133
 CU  A 602 (-3.1A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.3A)
 1.35A 3qpkA-3v9eA:
52.2		 3qpkA-3v9eA:
37.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_B_CUB601_0
(LACCASE-1)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
ILE A 491
HIS A 494
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-4.0A)
CU  A 601 (-3.1A)
 0.30A 3qpkB-3v9eA:
52.3		 3qpkB-3v9eA:
37.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_B_CUB602_0
(LACCASE-1)		 3v9e LACCASE
(Botrytis
aclada) 		3 / 3 HIS A 133
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.25A 3qpkB-3v9eA:
52.3		 3qpkB-3v9eA:
37.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_B_CUB603_0
(LACCASE-1)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  89
TRP A 129
HIS A 131
HIS A 490
 CU  A 603 (-2.9A)
CU  A 603 (-4.0A)
CU  A 603 (-3.2A)
CU  A 603 (-3.5A)
 0.33A 3qpkB-3v9eA:
52.3		 3qpkB-3v9eA:
37.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_B_CUB604_0
(LACCASE-1)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.43A 3qpkB-3v9eA:
52.3		 3qpkB-3v9eA:
37.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QPK_B_CUB604_0
(LACCASE-1)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.25A 3qpkB-3v9eA:
52.3		 3qpkB-3v9eA:
37.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_A_ZPCA1318_2
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 7 PHE A 393
TYR A 397
VAL A 399
GLU A 390
 None
 1.01A 4a97E-3v9eA:
undetectable		 4a97E-3v9eA:
19.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_D_ZPCD1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 8 PHE A 393
TYR A 397
VAL A 399
GLU A 390
 None
 1.10A 4a97C-3v9eA:
undetectable		 4a97C-3v9eA:
19.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_E_ZPCE1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 8 PHE A 393
TYR A 397
VAL A 399
GLU A 390
 None
 0.96A 4a97D-3v9eA:
undetectable		 4a97D-3v9eA:
19.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_H_ZPCH1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 8 PHE A 393
TYR A 397
VAL A 399
GLU A 390
 None
 1.02A 4a97G-3v9eA:
undetectable		 4a97G-3v9eA:
19.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_I_ZPCI1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 7 PHE A 393
TYR A 397
VAL A 399
GLU A 390
 None
 1.03A 4a97H-3v9eA:
undetectable		 4a97H-3v9eA:
19.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_J_ZPCJ1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 8 PHE A 393
TYR A 397
VAL A 399
GLU A 390
 None
 1.01A 4a97I-3v9eA:
undetectable		 4a97I-3v9eA:
19.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1001_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
HIS A 494
MET A 499
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-3.1A)
CU  A 601 (-3.1A)
 0.18A 4ef3A-3v9eA:
29.7		 4ef3A-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1002_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  89
HIS A 131
HIS A 429
HIS A 490
 CU  A 603 (-2.9A)
CU  A 603 (-3.2A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 0.31A 4ef3A-3v9eA:
29.7		 4ef3A-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1002_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 488
HIS A 431
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.17A 4ef3A-3v9eA:
29.7		 4ef3A-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1002_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 431
HIS A 488
HIS A  87
HIS A 133
 CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.3A)
 0.73A 4ef3A-3v9eA:
29.7		 4ef3A-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1003_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A  87
HIS A 133
HIS A 429
HIS A 431
HIS A 488
 CU  A 602 ( 4.7A)
CU  A 602 (-3.3A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.49A 4ef3A-3v9eA:
29.7		 4ef3A-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1003_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A  89
HIS A  87
HIS A 488
HIS A 429
HIS A 431
 CU  A 603 (-2.9A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 1.34A 4ef3A-3v9eA:
29.7		 4ef3A-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1003_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A 429
HIS A 490
HIS A  87
HIS A  89
HIS A 131
 CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-3.2A)
 0.69A 4ef3A-3v9eA:
29.7		 4ef3A-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1003_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A 490
HIS A 429
HIS A 133
HIS A 488
HIS A 431
 CU  A 603 (-3.5A)
CU  A 602 (-3.6A)
CU  A 602 (-3.3A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.32A 4ef3A-3v9eA:
29.7		 4ef3A-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1004_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.49A 4ef3A-3v9eA:
29.7		 4ef3A-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1004_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.31A 4ef3A-3v9eA:
29.7		 4ef3A-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EF3_A_CUA1004_0
(BLUE COPPER OXIDASE
CUEO)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 488
HIS A 429
HIS A  89
HIS A 490
 CU  A 602 (-3.1A)
CU  A 602 (-3.6A)
CU  A 603 (-2.9A)
CU  A 603 (-3.5A)
 1.39A 4ef3A-3v9eA:
29.7		 4ef3A-3v9eA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJJ_A_NCTA501_1
(CYTOCHROME P450 2A6)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 7 PHE A 120
GLY A  90
THR A 128
ILE A 148
 None
 0.86A 4ejjA-3v9eA:
undetectable		 4ejjA-3v9eA:
19.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MWR_A_ZMRA513_2
(NEURAMINIDASE)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 LEU A 230
ASP A 275
ARG A 229
ILE A 147
 None
 1.42A 4mwrA-3v9eA:
undetectable		 4mwrA-3v9eA:
21.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PGF_A_ADNA502_2
(ADENOSYLHOMOCYSTEINA
SE)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 6 THR A 383
THR A 382
HIS A 433
LEU A  97
 None
 1.07A 4pgfA-3v9eA:
undetectable		 4pgfA-3v9eA:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_A_HQEA503_1
(CATALASE)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 9 ILE A 475
PHE A 503
LEU A 430
LEU A 402
ASP A 480
 None
 1.29A 4qopA-3v9eA:
undetectable		 4qopA-3v9eA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QOP_B_HQEB503_1
(CATALASE)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 9 ILE A 475
PHE A 503
LEU A 430
LEU A 402
ASP A 480
 None
 1.29A 4qopB-3v9eA:
undetectable		 4qopB-3v9eA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QTU_D_SAMD301_0
(PUTATIVE
METHYLTRANSFERASE
BUD23)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 12 GLY A 141
GLY A 139
SER A 132
SER A  50
ALA A  51
 None
 1.11A 4qtuD-3v9eA:
undetectable		 4qtuD-3v9eA:
15.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4W9N_C_CCSC1548_0
(ENOYL-[ACYL-CARRIER-
PROTEIN] REDUCTASE)		 3v9e LACCASE
(Botrytis
aclada) 		3 / 3 ALA A 476
TRP A 411
VAL A 412
 None
 0.43A 4w9nC-3v9eA:
undetectable		 4w9nC-3v9eA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XDQ_A_BEZA306_0
(GLYCOSIDE HYDROLASE
FAMILY PROTEIN)		 3v9e LACCASE
(Botrytis
aclada) 		3 / 3 ARG A 181
ASP A 178
TRP A 177
 None
NAG  A 605 (-3.3A)
None
 1.14A 4xdqA-3v9eA:
undetectable		 4xdqA-3v9eA:
17.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XQE_A_AG2A506_1
(HOMOSPERMIDINE
SYNTHASE)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 6 ARG A  92
ASP A 480
VAL A  24
ASP A  23
 None
 1.41A 4xqeA-3v9eA:
undetectable		 4xqeA-3v9eA:
21.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XQE_B_AG2B505_1
(HOMOSPERMIDINE
SYNTHASE)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 6 ARG A  92
ASP A 480
VAL A  24
ASP A  23
 None
 1.40A 4xqeB-3v9eA:
undetectable		 4xqeB-3v9eA:
21.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XUD_A_SAMA303_0
(CATECHOL
O-METHYLTRANSFERASE)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 12 GLY A 101
TYR A  99
ILE A  86
SER A 132
GLN A 137
 None
 1.45A 4xudA-3v9eA:
undetectable		 4xudA-3v9eA:
14.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XUE_B_SAMB303_0
(CATECHOL
O-METHYLTRANSFERASE)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 12 GLY A 101
TYR A  99
ILE A  86
SER A 132
GLN A 137
 None
 1.41A 4xueB-3v9eA:
undetectable		 4xueB-3v9eA:
14.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_1
(BETA-LACTOGLOBULIN)		 3v9e LACCASE
(Botrytis
aclada) 		3 / 3 LYS A 225
ILE A 277
ILE A 251
 None
 0.67A 4y0qA-3v9eA:
undetectable		 4y0qA-3v9eA:
15.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5C0O_F_SAMF301_0
(TRNA
(ADENINE(58)-N(1))-M
ETHYLTRANSFERASE
TRMI)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 12 THR A 420
GLY A 471
GLY A 469
GLY A 423
ALA A 474
 None
 0.96A 5c0oF-3v9eA:
undetectable		 5c0oF-3v9eA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JWA_H_ACTH612_0
(NADH DEHYDROGENASE,
PUTATIVE)		 3v9e LACCASE
(Botrytis
aclada) 		3 / 3 ARG A 461
PRO A 341
ASN A 253
 None
 1.03A 5jwaA-3v9eA:
undetectable
5jwaH-3v9eA:
undetectable		 5jwaA-3v9eA:
21.95
5jwaH-3v9eA:
21.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LSA_A_SAMA303_0
(CATECHOL
O-METHYLTRANSFERASE)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 12 GLY A 101
TYR A  99
ILE A  86
SER A 132
GLN A 137
 None
 1.37A 5lsaA-3v9eA:
undetectable		 5lsaA-3v9eA:
15.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA501_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A  87
HIS A 133
HIS A 429
HIS A 431
HIS A 488
 CU  A 602 ( 4.7A)
CU  A 602 (-3.3A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.49A 5mejA-3v9eA:
44.2		 5mejA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA501_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A 429
HIS A 490
HIS A  87
HIS A  89
HIS A 131
 CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-3.2A)
 0.64A 5mejA-3v9eA:
44.2		 5mejA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA502_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		6 / 6 HIS A  87
HIS A  89
TRP A 129
HIS A 131
HIS A 429
HIS A 490
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-4.0A)
CU  A 603 (-3.2A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 0.34A 5mejA-3v9eA:
44.2		 5mejA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA502_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 6 HIS A 429
HIS A 488
HIS A  87
HIS A 133
 CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.3A)
 0.42A 5mejA-3v9eA:
44.2		 5mejA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA502_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 6 HIS A 431
HIS A 488
HIS A  87
HIS A 133
 CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.3A)
 0.66A 5mejA-3v9eA:
44.2		 5mejA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA503_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.42A 5mejA-3v9eA:
44.2		 5mejA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA503_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 131
HIS A  87
HIS A 429
HIS A 490
 CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 1.22A 5mejA-3v9eA:
44.2		 5mejA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA503_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 429
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 1.16A 5mejA-3v9eA:
44.2		 5mejA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA503_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.25A 5mejA-3v9eA:
44.2		 5mejA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEJ_A_CUA504_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
ILE A 491
HIS A 494
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-4.0A)
CU  A 601 (-3.1A)
 0.12A 5mejA-3v9eA:
44.2		 5mejA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA501_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A  87
HIS A 133
HIS A 429
HIS A 431
HIS A 488
 CU  A 602 ( 4.7A)
CU  A 602 (-3.3A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.49A 5mewA-3v9eA:
44.1		 5mewA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA501_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A 429
HIS A 490
HIS A  87
HIS A  89
HIS A 131
 CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-3.2A)
 0.63A 5mewA-3v9eA:
44.1		 5mewA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA502_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		6 / 6 HIS A  87
HIS A  89
TRP A 129
HIS A 131
HIS A 429
HIS A 490
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-4.0A)
CU  A 603 (-3.2A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 0.34A 5mewA-3v9eA:
44.1		 5mewA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA502_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 6 HIS A 429
HIS A 488
HIS A  87
HIS A 133
 CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.3A)
 0.42A 5mewA-3v9eA:
44.1		 5mewA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA502_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 6 HIS A 431
HIS A 488
HIS A  87
HIS A 133
 CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.3A)
 0.66A 5mewA-3v9eA:
44.1		 5mewA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA503_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.43A 5mewA-3v9eA:
44.1		 5mewA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA503_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 131
HIS A  87
HIS A 429
HIS A 490
 CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 1.22A 5mewA-3v9eA:
44.1		 5mewA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA503_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 429
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 1.16A 5mewA-3v9eA:
44.1		 5mewA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA503_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.25A 5mewA-3v9eA:
44.1		 5mewA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MEW_A_CUA504_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
ILE A 491
HIS A 494
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-4.0A)
CU  A 601 (-3.1A)
 0.12A 5mewA-3v9eA:
44.2		 5mewA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA501_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A  87
HIS A 133
HIS A 429
HIS A 431
HIS A 488
 CU  A 602 ( 4.7A)
CU  A 602 (-3.3A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.49A 5mhuA-3v9eA:
44.1		 5mhuA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA501_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A 429
HIS A 490
HIS A  87
HIS A  89
HIS A 131
 CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-3.2A)
 0.64A 5mhuA-3v9eA:
44.1		 5mhuA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA502_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		6 / 6 HIS A  87
HIS A  89
TRP A 129
HIS A 131
HIS A 429
HIS A 490
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-4.0A)
CU  A 603 (-3.2A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 0.35A 5mhuA-3v9eA:
44.1		 5mhuA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA502_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 6 HIS A 429
HIS A 488
HIS A  87
HIS A 133
 CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.3A)
 0.41A 5mhuA-3v9eA:
44.1		 5mhuA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA502_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 6 HIS A 431
HIS A 488
HIS A  87
HIS A 133
 CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.3A)
 0.66A 5mhuA-3v9eA:
44.1		 5mhuA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA503_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.42A 5mhuA-3v9eA:
44.1		 5mhuA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA503_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 131
HIS A  87
HIS A 429
HIS A 490
 CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 1.21A 5mhuA-3v9eA:
44.1		 5mhuA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA503_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 429
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 1.15A 5mhuA-3v9eA:
44.1		 5mhuA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA503_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.26A 5mhuA-3v9eA:
44.1		 5mhuA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHU_A_CUA504_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
ILE A 491
HIS A 494
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-4.0A)
CU  A 601 (-3.1A)
 0.12A 5mhuA-3v9eA:
44.1		 5mhuA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA501_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A  87
HIS A 133
HIS A 429
HIS A 431
HIS A 488
 CU  A 602 ( 4.7A)
CU  A 602 (-3.3A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.48A 5mhvA-3v9eA:
44.1		 5mhvA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA501_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A 429
HIS A 490
HIS A  87
HIS A  89
HIS A 131
 CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-3.2A)
 0.63A 5mhvA-3v9eA:
44.1		 5mhvA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA502_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		6 / 6 HIS A  87
HIS A  89
TRP A 129
HIS A 131
HIS A 429
HIS A 490
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-4.0A)
CU  A 603 (-3.2A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 0.34A 5mhvA-3v9eA:
44.1		 5mhvA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA502_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 6 HIS A 429
HIS A 488
HIS A  87
HIS A 133
 CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.3A)
 0.41A 5mhvA-3v9eA:
44.1		 5mhvA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA502_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 6 HIS A 431
HIS A 488
HIS A  87
HIS A 133
 CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.3A)
 0.67A 5mhvA-3v9eA:
44.1		 5mhvA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA503_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.41A 5mhvA-3v9eA:
44.2		 5mhvA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA503_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 131
HIS A  87
HIS A 429
HIS A 490
 CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 1.20A 5mhvA-3v9eA:
44.2		 5mhvA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA503_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 429
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 1.15A 5mhvA-3v9eA:
44.2		 5mhvA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA503_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.27A 5mhvA-3v9eA:
44.2		 5mhvA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA503_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 429
HIS A 490
HIS A 131
HIS A  87
 CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
 1.24A 5mhvA-3v9eA:
44.2		 5mhvA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHV_A_CUA504_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
ILE A 491
HIS A 494
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-4.0A)
CU  A 601 (-3.1A)
 0.12A 5mhvA-3v9eA:
44.1		 5mhvA-3v9eA:
33.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A 429
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.52A 5mhwA-3v9eA:
44.1		 5mhwA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 490
HIS A  87
HIS A  89
HIS A 131
 CU  A 603 (-3.5A)
CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-3.2A)
 0.60A 5mhwA-3v9eA:
44.1		 5mhwA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A  87
HIS A  89
TRP A 129
HIS A 131
HIS A 490
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-4.0A)
CU  A 603 (-3.2A)
CU  A 603 (-3.5A)
 0.23A 5mhwA-3v9eA:
44.2		 5mhwA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 HIS A 490
HIS A 429
HIS A 488
HIS A 431
 CU  A 603 (-3.5A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.95A 5mhwA-3v9eA:
44.2		 5mhwA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.41A 5mhwA-3v9eA:
44.2		 5mhwA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 131
HIS A  87
HIS A 429
HIS A 490
 CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 1.20A 5mhwA-3v9eA:
44.2		 5mhwA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 429
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 1.14A 5mhwA-3v9eA:
44.2		 5mhwA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.27A 5mhwA-3v9eA:
44.2		 5mhwA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 429
HIS A 490
HIS A 131
HIS A  87
 CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
 1.23A 5mhwA-3v9eA:
44.2		 5mhwA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHW_A_CUA604_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
ILE A 491
HIS A 494
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-4.0A)
CU  A 601 (-3.1A)
 0.12A 5mhwA-3v9eA:
44.1		 5mhwA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A 429
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.52A 5mhxA-3v9eA:
44.2		 5mhxA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 490
HIS A  87
HIS A  89
HIS A 131
 CU  A 603 (-3.5A)
CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-3.2A)
 0.61A 5mhxA-3v9eA:
44.2		 5mhxA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A  87
HIS A  89
TRP A 129
HIS A 131
HIS A 490
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-4.0A)
CU  A 603 (-3.2A)
CU  A 603 (-3.5A)
 0.24A 5mhxA-3v9eA:
44.2		 5mhxA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 HIS A 490
HIS A 429
HIS A 488
HIS A 431
 CU  A 603 (-3.5A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.95A 5mhxA-3v9eA:
44.2		 5mhxA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.40A 5mhxA-3v9eA:
44.2		 5mhxA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 131
HIS A  87
HIS A 429
HIS A 490
 CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 1.20A 5mhxA-3v9eA:
44.2		 5mhxA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 429
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 1.14A 5mhxA-3v9eA:
44.2		 5mhxA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.27A 5mhxA-3v9eA:
44.2		 5mhxA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 429
HIS A 490
HIS A 131
HIS A  87
 CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
 1.23A 5mhxA-3v9eA:
44.2		 5mhxA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHX_A_CUA604_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
ILE A 491
HIS A 494
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-4.0A)
CU  A 601 (-3.1A)
 0.12A 5mhxA-3v9eA:
44.2		 5mhxA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A 429
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.52A 5mhyA-3v9eA:
44.0		 5mhyA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 490
HIS A  87
HIS A  89
HIS A 131
 CU  A 603 (-3.5A)
CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-3.2A)
 0.61A 5mhyA-3v9eA:
44.0		 5mhyA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A  87
HIS A  89
TRP A 129
HIS A 131
HIS A 490
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-4.0A)
CU  A 603 (-3.2A)
CU  A 603 (-3.5A)
 0.24A 5mhyA-3v9eA:
44.1		 5mhyA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 HIS A 490
HIS A 429
HIS A 488
HIS A 431
 CU  A 603 (-3.5A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.96A 5mhyA-3v9eA:
44.1		 5mhyA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.40A 5mhyA-3v9eA:
44.1		 5mhyA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 131
HIS A  87
HIS A 429
HIS A 490
 CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 1.20A 5mhyA-3v9eA:
44.1		 5mhyA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 429
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 1.14A 5mhyA-3v9eA:
44.1		 5mhyA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.27A 5mhyA-3v9eA:
44.1		 5mhyA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 429
HIS A 490
HIS A 131
HIS A  87
 CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
 1.23A 5mhyA-3v9eA:
44.1		 5mhyA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHY_A_CUA604_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
ILE A 491
HIS A 494
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-4.0A)
CU  A 601 (-3.1A)
 0.12A 5mhyA-3v9eA:
44.1		 5mhyA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A 429
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.52A 5mhzA-3v9eA:
44.1		 5mhzA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 490
HIS A  87
HIS A  89
HIS A 131
 CU  A 603 (-3.5A)
CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-3.2A)
 0.60A 5mhzA-3v9eA:
44.1		 5mhzA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A  87
HIS A  89
TRP A 129
HIS A 131
HIS A 490
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-4.0A)
CU  A 603 (-3.2A)
CU  A 603 (-3.5A)
 0.24A 5mhzA-3v9eA:
44.2		 5mhzA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 HIS A 490
HIS A 429
HIS A 488
HIS A 431
 CU  A 603 (-3.5A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.96A 5mhzA-3v9eA:
44.2		 5mhzA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.40A 5mhzA-3v9eA:
44.2		 5mhzA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 131
HIS A  87
HIS A 429
HIS A 490
 CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 1.20A 5mhzA-3v9eA:
44.2		 5mhzA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 429
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 1.14A 5mhzA-3v9eA:
44.2		 5mhzA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.28A 5mhzA-3v9eA:
44.2		 5mhzA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 429
HIS A 490
HIS A 131
HIS A  87
 CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
 1.23A 5mhzA-3v9eA:
44.2		 5mhzA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MHZ_A_CUA604_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
ILE A 491
HIS A 494
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-4.0A)
CU  A 601 (-3.1A)
 0.12A 5mhzA-3v9eA:
44.2		 5mhzA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A 429
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.52A 5mi1A-3v9eA:
44.2		 5mi1A-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 490
HIS A  87
HIS A  89
HIS A 131
 CU  A 603 (-3.5A)
CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-3.2A)
 0.61A 5mi1A-3v9eA:
44.2		 5mi1A-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A  87
HIS A  89
TRP A 129
HIS A 131
HIS A 490
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-4.0A)
CU  A 603 (-3.2A)
CU  A 603 (-3.5A)
 0.24A 5mi1A-3v9eA:
44.1		 5mi1A-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 HIS A 490
HIS A 429
HIS A 488
HIS A 431
 CU  A 603 (-3.5A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.96A 5mi1A-3v9eA:
44.1		 5mi1A-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.40A 5mi1A-3v9eA:
44.2		 5mi1A-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 131
HIS A  87
HIS A 429
HIS A 490
 CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 1.19A 5mi1A-3v9eA:
44.2		 5mi1A-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 429
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 1.14A 5mi1A-3v9eA:
44.2		 5mi1A-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.28A 5mi1A-3v9eA:
44.2		 5mi1A-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 429
HIS A 490
HIS A 131
HIS A  87
 CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
 1.22A 5mi1A-3v9eA:
44.2		 5mi1A-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI1_A_CUA604_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
ILE A 491
HIS A 494
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-4.0A)
CU  A 601 (-3.1A)
 0.12A 5mi1A-3v9eA:
44.2		 5mi1A-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A 429
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.52A 5mi2A-3v9eA:
44.1		 5mi2A-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 490
HIS A  87
HIS A  89
HIS A 131
 CU  A 603 (-3.5A)
CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-3.2A)
 0.61A 5mi2A-3v9eA:
44.1		 5mi2A-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A  87
HIS A  89
TRP A 129
HIS A 131
HIS A 490
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-4.0A)
CU  A 603 (-3.2A)
CU  A 603 (-3.5A)
 0.24A 5mi2A-3v9eA:
44.1		 5mi2A-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 HIS A 490
HIS A 429
HIS A 488
HIS A 431
 CU  A 603 (-3.5A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.96A 5mi2A-3v9eA:
44.1		 5mi2A-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.39A 5mi2A-3v9eA:
44.1		 5mi2A-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 131
HIS A  87
HIS A 429
HIS A 490
 CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 1.19A 5mi2A-3v9eA:
44.1		 5mi2A-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 429
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 1.14A 5mi2A-3v9eA:
44.1		 5mi2A-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.28A 5mi2A-3v9eA:
44.1		 5mi2A-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 429
HIS A 490
HIS A 131
HIS A  87
 CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
 1.22A 5mi2A-3v9eA:
44.1		 5mi2A-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MI2_A_CUA604_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
ILE A 491
HIS A 494
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-4.0A)
CU  A 601 (-3.1A)
 0.12A 5mi2A-3v9eA:
44.1		 5mi2A-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A 429
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.52A 5miaA-3v9eA:
44.2		 5miaA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 490
HIS A  87
HIS A  89
HIS A 131
 CU  A 603 (-3.5A)
CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-3.2A)
 0.61A 5miaA-3v9eA:
44.2		 5miaA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A  87
HIS A  89
TRP A 129
HIS A 131
HIS A 490
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-4.0A)
CU  A 603 (-3.2A)
CU  A 603 (-3.5A)
 0.24A 5miaA-3v9eA:
44.2		 5miaA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 HIS A 490
HIS A 429
HIS A 488
HIS A 431
 CU  A 603 (-3.5A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.96A 5miaA-3v9eA:
44.2		 5miaA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.40A 5miaA-3v9eA:
44.2		 5miaA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 131
HIS A  87
HIS A 429
HIS A 490
 CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 1.19A 5miaA-3v9eA:
44.2		 5miaA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 429
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 1.14A 5miaA-3v9eA:
44.2		 5miaA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.29A 5miaA-3v9eA:
44.2		 5miaA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 429
HIS A 490
HIS A 131
HIS A  87
 CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
 1.22A 5miaA-3v9eA:
44.2		 5miaA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIA_A_CUA604_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
ILE A 491
HIS A 494
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-4.0A)
CU  A 601 (-3.1A)
 0.12A 5miaA-3v9eA:
44.2		 5miaA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A 429
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.52A 5mibA-3v9eA:
44.1		 5mibA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 490
HIS A  87
HIS A  89
HIS A 131
 CU  A 603 (-3.5A)
CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-3.2A)
 0.61A 5mibA-3v9eA:
44.1		 5mibA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A  87
HIS A  89
TRP A 129
HIS A 131
HIS A 490
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-4.0A)
CU  A 603 (-3.2A)
CU  A 603 (-3.5A)
 0.24A 5mibA-3v9eA:
44.1		 5mibA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 HIS A 490
HIS A 429
HIS A 488
HIS A 431
 CU  A 603 (-3.5A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.96A 5mibA-3v9eA:
44.1		 5mibA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.40A 5mibA-3v9eA:
44.1		 5mibA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 131
HIS A  87
HIS A 429
HIS A 490
 CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 1.19A 5mibA-3v9eA:
44.1		 5mibA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 429
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 1.13A 5mibA-3v9eA:
44.1		 5mibA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.28A 5mibA-3v9eA:
44.1		 5mibA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 429
HIS A 490
HIS A 131
HIS A  87
 CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
 1.22A 5mibA-3v9eA:
44.1		 5mibA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIB_A_CUA604_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
ILE A 491
HIS A 494
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-4.0A)
CU  A 601 (-3.1A)
 0.13A 5mibA-3v9eA:
44.1		 5mibA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A 429
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.52A 5micA-3v9eA:
44.1		 5micA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 490
HIS A  87
HIS A  89
HIS A 131
 CU  A 603 (-3.5A)
CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-3.2A)
 0.61A 5micA-3v9eA:
44.1		 5micA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A  87
HIS A  89
TRP A 129
HIS A 131
HIS A 490
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-4.0A)
CU  A 603 (-3.2A)
CU  A 603 (-3.5A)
 0.24A 5micA-3v9eA:
44.2		 5micA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 HIS A 490
HIS A 429
HIS A 488
HIS A 431
 CU  A 603 (-3.5A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.97A 5micA-3v9eA:
44.2		 5micA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.39A 5micA-3v9eA:
44.2		 5micA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 131
HIS A  87
HIS A 429
HIS A 490
 CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 1.19A 5micA-3v9eA:
44.2		 5micA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 429
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 1.13A 5micA-3v9eA:
44.2		 5micA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.28A 5micA-3v9eA:
44.2		 5micA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 429
HIS A 490
HIS A 131
HIS A  87
 CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
 1.22A 5micA-3v9eA:
44.2		 5micA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIC_A_CUA604_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
ILE A 491
HIS A 494
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-4.0A)
CU  A 601 (-3.1A)
 0.12A 5micA-3v9eA:
44.1		 5micA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A 429
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.52A 5midA-3v9eA:
44.2		 5midA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 490
HIS A  87
HIS A  89
HIS A 131
 CU  A 603 (-3.5A)
CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-3.2A)
 0.61A 5midA-3v9eA:
44.2		 5midA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A  87
HIS A  89
TRP A 129
HIS A 131
HIS A 490
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-4.0A)
CU  A 603 (-3.2A)
CU  A 603 (-3.5A)
 0.24A 5midA-3v9eA:
44.2		 5midA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 HIS A 490
HIS A 429
HIS A 488
HIS A 431
 CU  A 603 (-3.5A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.97A 5midA-3v9eA:
44.2		 5midA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.39A 5midA-3v9eA:
44.2		 5midA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 131
HIS A  87
HIS A 429
HIS A 490
 CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 1.19A 5midA-3v9eA:
44.2		 5midA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 429
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 1.13A 5midA-3v9eA:
44.2		 5midA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.28A 5midA-3v9eA:
44.2		 5midA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 429
HIS A 490
HIS A 131
HIS A  87
 CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
 1.22A 5midA-3v9eA:
44.2		 5midA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 488
HIS A 429
HIS A 431
HIS A 133
 CU  A 602 (-3.1A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.3A)
 1.31A 5midA-3v9eA:
44.2		 5midA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MID_A_CUA604_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
ILE A 491
HIS A 494
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-4.0A)
CU  A 601 (-3.1A)
 0.12A 5midA-3v9eA:
44.2		 5midA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A 429
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.52A 5mieA-3v9eA:
44.2		 5mieA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 490
HIS A  87
HIS A  89
HIS A 131
 CU  A 603 (-3.5A)
CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-3.2A)
 0.61A 5mieA-3v9eA:
44.2		 5mieA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A  87
HIS A  89
TRP A 129
HIS A 131
HIS A 490
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-4.0A)
CU  A 603 (-3.2A)
CU  A 603 (-3.5A)
 0.24A 5mieA-3v9eA:
44.2		 5mieA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 HIS A 490
HIS A 429
HIS A 488
HIS A 431
 CU  A 603 (-3.5A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.97A 5mieA-3v9eA:
44.2		 5mieA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.39A 5mieA-3v9eA:
44.2		 5mieA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 131
HIS A  87
HIS A 429
HIS A 490
 CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 1.19A 5mieA-3v9eA:
44.2		 5mieA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 429
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 1.13A 5mieA-3v9eA:
44.2		 5mieA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.29A 5mieA-3v9eA:
44.2		 5mieA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 429
HIS A 490
HIS A 131
HIS A  87
 CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
 1.22A 5mieA-3v9eA:
44.2		 5mieA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 488
HIS A 429
HIS A 431
HIS A 133
 CU  A 602 (-3.1A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.3A)
 1.31A 5mieA-3v9eA:
44.2		 5mieA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIE_A_CUA604_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
ILE A 491
HIS A 494
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-4.0A)
CU  A 601 (-3.1A)
 0.12A 5mieA-3v9eA:
44.2		 5mieA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA601_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		3 / 3 HIS A 133
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.27A 5migA-3v9eA:
44.2		 5migA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 5 HIS A  87
HIS A  89
TRP A 129
HIS A 131
HIS A 490
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 603 (-4.0A)
CU  A 603 (-3.2A)
CU  A 603 (-3.5A)
 0.25A 5migA-3v9eA:
44.2		 5migA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA602_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 HIS A 490
HIS A 429
HIS A 488
HIS A 431
 CU  A 603 (-3.5A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 0.97A 5migA-3v9eA:
44.2		 5migA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A  87
HIS A  89
HIS A 429
HIS A 431
 CU  A 602 ( 4.7A)
CU  A 603 (-2.9A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 0.39A 5migA-3v9eA:
44.2		 5migA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 131
HIS A  87
HIS A 429
HIS A 490
 CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
 1.20A 5migA-3v9eA:
44.2		 5migA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 429
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
 1.13A 5migA-3v9eA:
44.2		 5migA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 133
HIS A  87
HIS A 431
HIS A 488
 CU  A 602 (-3.3A)
CU  A 602 ( 4.7A)
CU  A 602 (-3.1A)
CU  A 602 (-3.1A)
 1.29A 5migA-3v9eA:
44.2		 5migA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 429
HIS A 490
HIS A 131
HIS A  87
 CU  A 602 (-3.6A)
CU  A 603 (-3.5A)
CU  A 603 (-3.2A)
CU  A 602 ( 4.7A)
 1.23A 5migA-3v9eA:
44.2		 5migA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA603_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 488
HIS A 429
HIS A 431
HIS A 133
 CU  A 602 (-3.1A)
CU  A 602 (-3.6A)
CU  A 602 (-3.1A)
CU  A 602 (-3.3A)
 1.31A 5migA-3v9eA:
44.2		 5migA-3v9eA:
33.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIG_A_CUA604_0
(LACCASE 2)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 4 HIS A 426
CYH A 489
ILE A 491
HIS A 494
 CU  A 601 (-3.1A)
CU  A 601 (-2.2A)
CU  A 601 (-4.0A)
CU  A 601 (-3.1A)
 0.11A 5migA-3v9eA:
44.2		 5migA-3v9eA:
33.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BXN_A_SAMA901_0
(DIPHTHAMIDE
BIOSYNTHESIS ENZYME
DPH2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 12 LEU A 486
HIS A 488
GLN A 107
VAL A  75
ILE A  86
 None
CU  A 602 (-3.1A)
None
None
None
 1.47A 6bxnA-3v9eA:
undetectable		 6bxnA-3v9eA:
18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BXN_B_SAMB901_0
(DIPHTHAMIDE
BIOSYNTHESIS ENZYME
DPH2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 12 GLY A 271
HIS A  89
VAL A 250
ARG A 273
ASP A 275
 None
CU  A 603 (-2.9A)
None
None
None
 1.29A 6bxnB-3v9eA:
undetectable		 6bxnB-3v9eA:
18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BXN_B_SAMB901_0
(DIPHTHAMIDE
BIOSYNTHESIS ENZYME
DPH2)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 12 LEU A 486
HIS A 488
GLN A 107
VAL A  75
ILE A  86
 None
CU  A 602 (-3.1A)
None
None
None
 1.48A 6bxnB-3v9eA:
undetectable		 6bxnB-3v9eA:
18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DYO_A_LDPA901_0
(EBONY)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 5 GLU A 355
VAL A 400
LEU A 402
HIS A 433
 NAG  A 612 (-4.3A)
None
None
None
 1.29A 6dyoA-3v9eA:
undetectable		 6dyoA-3v9eA:
8.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EKZ_A_SNPA413_0
(AROMATIC
PEROXYGENASE)		 3v9e LACCASE
(Botrytis
aclada) 		4 / 7 ASP A 167
GLN A 166
GLY A 269
SER A 237
 None
None
GOL  A 607 (-3.3A)
None
 0.97A 6ekzA-3v9eA:
undetectable		 6ekzA-3v9eA:
9.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EU9_B_REAB601_1
(RETINOIC ACID
RECEPTOR)		 3v9e LACCASE
(Botrytis
aclada) 		5 / 10 VAL A  75
LEU A  35
PHE A  54
GLY A 101
GLY A  83
 None
 1.20A 6eu9B-3v9eA:
undetectable		 6eu9B-3v9eA:
11.58